Imperial College London

ProfessorStuartHaslam

Faculty of Natural SciencesDepartment of Life Sciences

Professor in Structural Glycobiology
 
 
 
//

Contact

 

+44 (0)20 7594 5222s.haslam

 
 
//

Location

 

101ASir Ernst Chain BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{North:2019:glycob/cwz035,
author = {North, SJ and Botchway, K and Doonan, J and Lumb, FE and Dell, A and Harnett, W and Haslam, SM},
doi = {glycob/cwz035},
journal = {Glycobiology},
pages = {562--571},
title = {Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae},
url = {http://dx.doi.org/10.1093/glycob/cwz035},
volume = {29},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - ES-62 is the major secreted product of the parasitic filarial nematode Acanthocheilonema viteae and has potent anti-inflammatory activities as a consequence of post-translational decoration by phosphorylcholine. Previously we showed that ES-62's phosphorylcholine was attached to N-linked glycans and using fast atom bombardment mass spectrometry, we characterised the structure of the glycans. However, it was unknown at this time which of ES-62's four potential N-glycosylation sites carries the phosphorylcholine-modified glycans. In the present study, we now employ more advanced analytical tools - nano-flow liquid chromatography with high definition electrospray mass spectrometry - to show that phosphorylcholine-modified glycans are found at all four potential N-glycosylation sites. Also, our earlier studies showed up to two phosphorylcholine groups were detected per glycan and we are now able to characterise N-glycans with up to five phosphorylcholine groups. The number per glycan varies in three of the four glycosylation sites and in addition, for the first time, we have detected phosphorylcholine on the N-glycan chitobiose core in addition to terminal GlcNAc. Nevertheless, the majority of phosphorylcholine is detected on terminal GlcNAc, enabling it to interact with the cells and molecules of the immune system. Such expression may explain the potent immunomodulatory effects of a molecule that is considered to have significant therapeutic potential in the treatment of certain human allergic and autoimmune conditions.
AU - North,SJ
AU - Botchway,K
AU - Doonan,J
AU - Lumb,FE
AU - Dell,A
AU - Harnett,W
AU - Haslam,SM
DO - glycob/cwz035
EP - 571
PY - 2019///
SN - 0959-6658
SP - 562
TI - Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
T2 - Glycobiology
UR - http://dx.doi.org/10.1093/glycob/cwz035
UR - https://www.ncbi.nlm.nih.gov/pubmed/31094418
UR - http://hdl.handle.net/10044/1/70523
VL - 29
ER -